Physical Medicine & Rehabilitation · Fort Worth, TX
NPI
1477557437
Since 2005
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
7100 Oakmont Blvd Ste 207
Fort Worth, TX, 76132
Phone (817) 292-8585
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
959 services
Medicare patients, 2024
138
Average age 68
Drug cost, 2024
$211K
4,814 prescriptions
Company payments, 2025
$1,093
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rinoo V Shah was code 99213 (office e&m - established), 171 times for 83 patients. In total Rinoo V Shah billed 959 services in 62 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 171 | 83 | $66.16 | $11K |
| 99214 Office E&M - Established | Office | 157 | 69 | $82.06 | $13K |
| 80307 Drug Tests | Office | 102 | 81 | $60.34 | $6,155 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 44 | 42 | $194.77 | $8,570 |
| 99204 Office E&M - New | Office | 31 | 31 | $116.00 | $3,596 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 31 | 28 | $153.46 | $4,757 |
| 99203 Office E&M - New | Office | 29 | 29 | $83.13 | $2,411 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 28 | 25 | $108.35 | $3,034 |
| 27096 Joint Injection | Facility | 21 | 16 | $72.90 | $1,531 |
By year: 2022 $36K for 431 services; 2023 $60K for 671 services; 2024 $78K for 959 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 102 | 81 | $60.34 | $6,155 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 44 | 42 | $194.77 | $8,570 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 31 | 28 | $153.46 | $4,757 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 28 | 25 | $108.35 | $3,034 |
Medicare prescription drug claims, 2024
In 2024, the drug Rinoo V Shah prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,330 prescriptions and refills. In total Rinoo V Shah wrote 4,814 Medicare prescriptions that cost $211K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,330 | 1,330 | 274 | $42K |
| Gabapentin Generic | 441 | 455 | 133 | $4,666 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 333 | 333 | 73 | $13K |
| Meloxicam Generic | 264 | 280 | 89 | $368 |
| Pregabalin Generic | 227 | 235 | 55 | $9,858 |
| Tizanidine Hcl Generic | 165 | 212 | 58 | $1,753 |
| Methocarbamol Generic | 165 | 165 | 64 | $3,015 |
| Tramadol Hcl Generic | 154 | 155 | 54 | $1,631 |
| Duloxetine Hcl Generic | 119 | 135 | 37 | $1,945 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 113 | 113 | 30 | $2,515 |
| Nalbuphine Hcl Generic | 103 | 103 | Under 11 | $18K |
| Carisoprodol Generic | 101 | 101 | 23 | $484 |
| Cyclobenzaprine Hcl Generic | 100 | 122 | 27 | $1,123 |
| Baclofen Generic | 96 | 114 | 26 | $1,200 |
| Trazodone Hcl Generic | 78 | 100 | 14 | $322 |
Brand drugs: 192 claims; generic drugs: 4,622 claims; opioid claims: 2,222.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rinoo V Shah $1,093 ($1,093 in general payments such as food, travel and fees) from 4 companies. The largest payer was Medtronic, Inc. with $663.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.